Eptinezumab

🧮 Dose calculator

Migraine prophylaxis · Regimen source: FDA Vyepti · 2.1

• • Dilute only in 100 mL 0.9% sodium chloride. FDA Vyepti · 2.2

Enter age (weight is optional for this regimen).

👥 Special populations

• 🤰 PregnancyUse with caution

  Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Vyepti · 8.1

  “Risk Summary There are no adequate data on developmental risks associated with the use of VYEPTI in pregnant women.”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA Vyepti · 8.2

  “Risk Summary There are no data on the presence of eptinezumab-jjmr in human milk, the effects on the breastfed infant, or the effects on milk production.”

• 👶 ChildrenSafety not established

  Label: safety and effectiveness in children have not been established. FDA Vyepti · 8.4

  “Safety and effectiveness in pediatric patients have not been established.”

• 👴 Older adultsUse with caution

  Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Vyepti · 8.5

  “Clinical studies of VYEPTI did not include sufficient numbers of patients aged 65 and over to determine whether they respond differently from younger patients.”

• ⚥ Females & males of reproductive potentialNo data

  The source for this drug has no section for this group.